Ratiopharm Company Profile
On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm GmbH, Technilab Pharma and its group of companies, enjoyed a rich history and played an important role in the evolution of the Canadian generic industry.
Founded in 1974, with head office in Mirabel, Quebec, Technilab Pharma was a prominent player in the field of generic prescription drugs and over-the-counter medications. As Canada's leading manufacturer of liquid and topical generic drugs, Technilab Pharma marketed a wide range of products under the Technilab, Bio-Chimique, Charton and Rougier brands.
Location
6975 Creditview RoadUnit 5
Mississauga
Ontario
L5N 8E9
Canada
Contact
Phone: (905) 858-9612
Fax: (905) 858-9610
Email: webmaster@ratiopharm.ca
News Articles
ROUNDUP: Staatsanwaltschaft stellt Ratiopharm-Ermittlungen ein
Die Staatsanwaltschaft Ulm hat Ermittlungen gegen Verantwortliche der Pharmafirma Ratiopharm wegen umstrittener Zahlungen an niedergelassene Ärzte eingestellt. Das Unternehmen hatte diese am Umsat...
Comparison of EPARs for G-CSF biosimilars approved in Europe
EMA approved its first biosimilar granulocyte colony-stimulating factor (G-CSF, filgrastim) for use in Europe back in 2008, since then, several biosimilar G-CSFs have been approved, including Biograst...
Pending EC decision: Memantine ratiopharm, memantine hydrochloride, Opinion date: 21-Mar-2013
Drugs and Medications
These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE.RISPERIDONE tabletsInitial U.S. Approval 1993
PubMed Articles
Presently available biosimilars in hematology-oncology: G-CSF.
Biopharmaceuticals were copies of endogenous human proteins developed in the mid-1990s that were characterized by complex three-dimensional, high-molecular weight compounds. What made them unique was...
Peripheral blood haematopoietic progenitor cell mobilization has become a standard procedure prior to autologous stem cell transplantation. Biosimilar granulocyte colony-stimulating factors (GCSF) hav...
Clinical Trials
None
Companies
ratiopharm is one of the leading international generics producer and in our home country Germany the top selling and most commonly prescribed pharmaceutical brand. We produce high quality medicines an...
On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm Gm...
Die Merckle GmbH zählt zu den führenden Arzneimittelherstellern Europas. Zusammen mit dem Tochterunternehmen ratiopharm GmbH, der meistverwendeten und meistverordneten Arzneimittelmarke in Deutschla...
As a strategic start-up the BioGeneriX AG aims to develop bioengineered drugs for known targets. The unique character of BioGeneriX was moulded in a particular entrepreneurial setting within the exist...
More Information about "Ratiopharm" on BioPortfolio
We have published hundreds of Ratiopharm news stories on BioPortfolio along with dozens of Ratiopharm Clinical Trials and PubMed Articles about Ratiopharm for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ratiopharm Companies in our database. You can also find out about relevant Ratiopharm Drugs and Medications on this site too.
